Joint Honours Degree in Journalism and Media and Communications.
Junior Journalist at Orange Fox Media, creating content for vaping publications, media partnerships, and blogs. Journalist at The Cannavist, securing the UK's first commercial cannabis publication deal with WHSmiths and Easons in Ireland. Published numerous articles covering different aspects of the cannabis industry and interviewed experts. Collaborated on official media partnerships, including the Europe CBD Expo official show guide.
Vapouround, Evade Magazine, StudyInn.
Lucy is a respected journalist and content writer within the medical cannabis sector. Passionate about removing the stigma that surrounds cannabis-based treatments, and improving patient outcomes, Lucy is dedicated to creating high quality content that educates, informs, and raises awareness of medical cannabis in the UK. During her time at Releaf Lucy has spearheaded our 2023 market research report, Say No To Pain, which, as the UK’s largest study of attitudes towards medical cannabis, provided invaluable insight into the current medical cannabis climate in the UK. She has also been a large contributor to our blog and education section, and as well as producing medical cannabis patient travel guides, Lucy has helped to create one of the largest medical cannabis glossaries available online. Lucy started her content career in the vaping industry as a junior journalist and quickly segued into cannabis journalism in 2019. Lucy has previously written for The Cannavist, the UK’s first cannabis-based publication sold in high-street retailers such as W H Smiths and Easons in Ireland, has collaborated on official media partnerships including the Europe CBD Expo show guide, and has conducted in-depth interviews industry members, healthcare professionals, and patients alike.
People living with psoriasis often use a combination of topical and oral treatments, as well as phototherapy, to ease symptoms and cope with the condition. Recent research has shown CBD oil may have a positive impact on psoriasis symptoms. From easing stress to reducing inflammation, CBD products can potentially help to improve the lives of people living with the condition.
Psoriasis is a chronic skin condition that’s linked to the body’s immune system. It can emerge at any point in a person’s life but is most likely to develop between the ages of 15 and 25. People living with psoriasis experience increased skin cell production. This results in inflamed patches of skin appearing on the body. These patches are often covered with dry ‘scales’ and can cause irritation and pain to the sufferer.
Inflammatory Bowel Disease (IBD) is a group of conditions that cause inflammation in the digestive tract. Depending on their level of severity, they can be anything from frustrating inconveniences to life-altering health issues with potentially dangerous consequences.
To continue our commitment to spreading awareness, information, and education of cannabis-based medicines, we’ve put together our second statistics feature to cover five of the most impressive findings in medical cannabis research over the last decade or so.
Psoriasis is a chronic, autoimmune skin condition that affects an estimated 2.1 million people in the UK, and August marks its month of awareness. This extremely prevalent dermatological issue is currently incurable, and subjects patients to uncomfortable red, itchy patches of skin that can crack and bleed, which can be very painful.
Psoriasis affects around 2 in 100 people here in the UK and is characterised as a chronic, non-contagious autoimmune disease. It occurs when the body overproduces skin cells, resulting in patches of skin that are anything but ideal. These patches then often take on a dry white or red appearance, which causes itching and discomfort.
Housed in the tiny trichomes that coat the surface of cannabis buds, cannabinoids like CBD and terpenes like Myrcene are produced by female cannabis plants in a potent resin. These minuscule orbs of resin give cannabis its crystal-like encrusted appearance, and they can be extracted from the plant to be used in the manufacturing of cannabis-based products.
CBD oil is gaining attention for its potential role in cancer care, particularly for patients on immunotherapy. This guide explains how CBD works, what the research shows, potential benefits and risks, and how UK patients can access prescriptions safely through Releaf’s clinical team and one-of-a-kind Patient Dashboard.
For centuries, millennia even, humans have used the Cannabis sativa plant for its plethora of potentially beneficial properties. From clothing and sustainable textiles to pain relief and relaxation, this fascinating plant certainly has many uses. But it’s the emerging medical applications which are attracting the most recent attention, as research increasingly points to their benefits.
People with diabetes need to regulate their blood glucose level, usually by injecting insulin at regular intervals. Staying fit, healthy, and within weight limits can also help to mitigate the worst effects of diabetes.
Over the last few years, you may have heard CBD talked about a lot as a potential complementary medical cannabis treatment option. But you might not know exactly what CBD stands for, what it is and what it can be used for. The good news is, you’re not alone. There’s a great deal of confusion and misinformation out there about CBD, which might mean its potential benefits are not being accessed by those who most need them.
Many people suffering from Irritable Bowel Syndrome (IBS) are seeking out new complementary treatment options, such as cannabidiol (CBD), to treat symptomatic flare-ups. While there are conventional pharmaceutical options, some come with heavy side effects or simply do not bring the level of relief needed.
There is a significant body of research that suggests symptoms of irritable bowel syndrome (IBS) may be treated with medical cannabis, and more specifically, cannabidiol (CBD). Now, along with the increasing availability of CBD products through the NHS and private clinics (like Releaf) to treat certain conditions like IBS, it is worth understanding the benefits of CBD treatment, as well as its potential side effects and correct dosage amounts.
There are over three million people in the UK estimated to be suffering from irritable bowel syndrome (IBS) and its variety of symptoms. More and more treatments for the currently incurable condition are being sought, with one of the increasingly popular treatment options being medical cannabis, and one of the major cannabinoids produced by the plant - cannabidiol (CBD).
As more research is conducted into the potential therapeutic effects of medical cannabis and CBD oil, more possible benefits are discovered. One such discovery is the potential for CBD oil to help alleviate certain symptoms in people suffering from ulcerative colitis.
Crohn's disease is a chronic inflammatory bowel disease (IBD) that affects the gastrointestinal tract. It causes symptoms such as abdominal pain, diarrhoea, weight loss and fatigue. The condition can be difficult to manage, and traditional treatment methods may not always be effective. This has led some people to explore alternative, complementary therapies, such as medical cannabis.
Crohn's disease is an inflammatory bowel disease (IBD) that affects the gastrointestinal tract, most often the small intestine and colon. Its milder symptoms include diarrhoea and fatigue. More severe cases may cause intense abdominal pain and impaired digestion, leading to potential malnutrition. Crohn's disease can also trigger very distressing complications such as ulcers and fissures.
To help get a deeper understanding of the cannabis industry, we’ve decided to uncover and unravel some of the key statistics that shape the cannabis industry in the UK. In this piece, we will explore cannabis as a ‘cash crop’ by identifying its economic impact on the UK, and analysing these figures in the political and social landscapes that shape the United Kingdom today.
There are over three million people in the UK estimated to be suffering from Irritable Bowel Syndrome (IBS) and its variety of symptoms. More and more treatments for the currently incurable condition are being sought, with one of the increasingly popular treatment options being cannabidiol (CBD).
CBD engages with the body's endocannabinoid system, a vital regulatory system involved in managing numerous physiological processes, such as inflammation and immune response. In the case of Inflammatory Bowel Disease (IBD), the immune system erroneously targets the gastrointestinal tract, resulting in persistent inflammation. CBD has shown the potential to influence this immune response and mitigate inflammation within the digestive system.
The ECS may be influential in the treatment of psoriasis in a number of ways. Importantly, studies suggest that the main physiological function of the cutaneous ECS is to control the well-balanced proliferation, differentiation, and survival – as well as immune competence and/or tolerance – of skin cells.
Every single hour, two people in the UK are diagnosed with Parkinson’s Disease (PD), the world’s fastest growing neurological condition that currently has no cure. With an estimated 8.5 million people facing this incurable diagnosis across the world, increasing numbers of Parkinson’s patients are turning to medicinal cannabis to help potentially manage tremors and rigidity, relieve the symptoms of anxiety that can go hand in hand with the diagnosis, and improve their sleep quality.
On Monday the 3rd of July an Early Day Motion was submitted by MP Crispin Blunt, calling on the government to allow general practitioners the right to prescribe cannabis-based medications. This motion aims to open up prescription rights to the 36,000 General Practitioners that are currently practising in the UK in the hope of making medical cannabis more accessible.
Flower production begins once the vegetative stage of growth finishes up (anywhere between 3 weeks to 4 months after the seed sprouts), with the largest flower typically found on female cannabis plants in a cluster, or a cola, at its highest point. Flowers are also produced on the branches, but in smaller sizes than the main cola.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient
